MerTK Antibody MERTK/3015 / MERTK Monoclonal Antibody [clone MERTK/3015] (V7662)

MerTK Antibody MERTK/3015 in Human Colon IHC. Immunohistochemistry of FFPE human colon sections using MerTK Antibody clone MERTK/3015. The image shows distinct brown staining in cells associated with the colonic glandular structures, with comparatively limited staining across the surrounding tissue. The localized staining pattern provides clear contrast against the hematoxylin-counterstained sections and demonstrates detection of MERTK in normal human colon. HIER was performed by boiling sections in pH 9 10mM Tris with 1mM EDTA for 10-20 min before testing.

MerTK Antibody MERTK/3015 in Human Colon Carcinoma IHC. Immunohistochemistry of FFPE human colon carcinoma sections using MerTK Antibody clone MERTK/3015. The tumor shows readily visible brown immunoreactivity across neoplastic glandular structures, with staining distributed through substantial portions of the carcinoma. The pattern demonstrates MERTK detection in malignant colon tissue and complements the normal colon validation for this MERTK Monoclonal Antibody. HIER was performed by boiling sections in pH 9 10mM Tris with 1mM EDTA for 10-20 min before testing.

MerTK Antibody MERTK/3015 Protein Microarray Validation. Protein microarray analysis of MerTK Antibody clone MERTK/3015 using a HuProt array containing more than 19,000 full-length human proteins. MERTK produces the dominant signal, with a Z-score of approximately 119.7 and S-score of approximately 119.0, substantially separated from the next-ranked proteins. The Z-score represents signal strength in standard deviations above the array mean, while the S-score measures separation from the next-highest signal. The exceptionally large separation supports high target specificity and designation of this reagent as Protein Microarray Validated.

MerTK Antibody MERTK/3015 Purity by SDS-PAGE. SDS-PAGE analysis of 2 ug purified, BSA-free MerTK Antibody clone MERTK/3015 under non-reducing (NR) and reducing (R) conditions. The non-reduced sample shows the intact antibody predominantly near the expected ~150 kDa region, while reduction produces the expected immunoglobulin heavy- and light-chain components at approximately 50 kDa and 25 kDa. The gel provides confirmation of antibody integrity and purity and supports the defined monoclonal format of this MERTK Monoclonal Antibody.